Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jordanian FDA Drug Director Laila Jarrar On Collaborations With Korean Regulators To Spur Biologics Growth - An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

The fast-growing pharmaceutical market in the Middle East has seen an increasing demand for regulators to step up to new challenges such as biologics and biosimilars, and to answer the call they are enhancing collaborations with leading health authorities around the world.
Advertisement

Related Content

Saudi FDA Licensing Director Hajed Hashan On CTD And Drug Licensing: An Interview With PharmAsia News
Saudi FDA Licensing Director Hajed Hashan On CTD And Drug Licensing: An Interview With PharmAsia News
Jordanian Drug Maker Buys Baxter Injectable Business, Becomes Second Largest In U.S.
Jordan's Hikma Sees Double-digit Sales Growth In First Half, Continues Aggressive M&A Expansion In Middle East
Korea's Celltrion Banks On Increasing Profits Resulting From New Focus On Biosimilars
Korea's Celltrion Banks On Increasing Profits Resulting From New Focus On Biosimilars
Advertisement
UsernamePublicRestriction

Register

SC077176

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel